FARMINGTON, Conn.--(BUSINESS WIRE)--Evariant, a leading healthcare CRM and analytics solution built on Salesforce, announced today it has secured additional funding from McKesson Ventures and Salesforce Ventures as part of their Series C financing round. They join existing investors Health Enterprise Partners, Lightspeed Venture Partners, and Goldman, Sachs & Co.
“This additional investment positions Evariant to continue to help health systems and hospitals grow revenue through strategic patient acquisition and physician alignment,” stated Evariant Co-Founder and Chief Executive Officer, William Moschella. “By tapping big data and analytics, healthcare leaders can turn clinical data into meaningful insights that drive proactive health, and increased profitability.”
The Evariant healthcare CRM and analytics solution provides a 360-degree view of patients and physicians through big data and analytics to transform how health systems and hospitals engage with patients, consumers, and providers. According to recent industry research, hospitals that offer a superior patient experience tend to have 50% higher margins than their peers, and those that are fastest to adopt patient experience and digital health best-practices will be best positioned to improve their reputations, reap the financial rewards, and outperform their peers.1
“Evariant arms health systems with the tools needed to take complex internal and external data streams and generate marketing, financial, clinical, and operational insights so that they can deliver a more patient-centric approach to care,” said Tom Rodgers, SVP and managing director, McKesson Ventures. “By optimizing the data available, health systems gain the ability to identify, attract and engage the right patients and the right physicians which is becoming key as health systems shift their weight from traditional fee-for-service and establish their footing in a value-based world.”
“We are pleased that both McKesson Ventures and Salesforce Ventures have invested in Evariant, validating our mission to deliver the world’s most innovative healthcare CRM and analytics solution,” concluded Moschella.
Evariant clients include six of the top ten health systems in the United States, and more than 600 hospitals.
About McKesson Ventures
McKesson Ventures is the venture capital arm of McKesson Corporation specializing in early and growth stage companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. health care landscape. McKesson Corporation, currently ranked 11th on the FORTUNE 500, is a health care services and information technology company dedicated to making the business of health care run better. We work with payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and others across the spectrum of care to build healthier organizations that help deliver better care to patients in every setting. Visit www.mckessonventures.com to learn more.
About Salesforce Ventures
Salesforce Ventures—Salesforce’s corporate investment group—invests in the next generation of enterprise technology to help companies connect with their customers in entirely new ways. Portfolio companies receive funding as well as access to the world’s largest cloud ecosystem and the guidance of Salesforce’s innovators and executives. With Salesforce Ventures, portfolio companies can also leverage Salesforce's expertise in corporate philanthropy by joining Pledge 1% to make giving back part of their business model. Salesforce has invested in more than 150 enterprise cloud startups since 2009. For more information, please visit www.salesforce.com/ventures.
Evariant sees a future where healthcare organizations deliver precise, efficient care solutions not only inside an organization’s walls, but also beyond. We make this a reality by continuously innovating a healthcare CRM solution – a solution based on a centralized healthcare data hub, analytics, and communications engine - capable of identifying, executing, and measuring all types of engagement initiatives. The result is greater visibility into opportunities, richer engagement with key constituents, and continuous measurement and improvement. Many of the leading healthcare institutions have selected our solutions to optimize their care strategies and related initiatives. Learn more at www.evariant.com.
1 Collier, M. & Meyer Basham, L. (2015). Insight driven health – patient engagement: happy patients, healthy margins. Retrieved from Accenture: https://www.accenture.com